Cargando…

Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification

Detalles Bibliográficos
Autores principales: Luo, Liying, Guan, Zhiyuan, Jin, Xiao, Guan, Zhiqiang, Jiang, Yanyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122277/
https://www.ncbi.nlm.nih.gov/pubmed/37085763
http://dx.doi.org/10.1186/s10020-023-00654-1
_version_ 1785029460200783872
author Luo, Liying
Guan, Zhiyuan
Jin, Xiao
Guan, Zhiqiang
Jiang, Yanyun
author_facet Luo, Liying
Guan, Zhiyuan
Jin, Xiao
Guan, Zhiqiang
Jiang, Yanyun
author_sort Luo, Liying
collection PubMed
description
format Online
Article
Text
id pubmed-10122277
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101222772023-04-23 Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification Luo, Liying Guan, Zhiyuan Jin, Xiao Guan, Zhiqiang Jiang, Yanyun Mol Med Correction BioMed Central 2023-04-21 /pmc/articles/PMC10122277/ /pubmed/37085763 http://dx.doi.org/10.1186/s10020-023-00654-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Luo, Liying
Guan, Zhiyuan
Jin, Xiao
Guan, Zhiqiang
Jiang, Yanyun
Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
title Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
title_full Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
title_fullStr Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
title_full_unstemmed Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
title_short Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
title_sort correction: identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122277/
https://www.ncbi.nlm.nih.gov/pubmed/37085763
http://dx.doi.org/10.1186/s10020-023-00654-1
work_keys_str_mv AT luoliying correctionidentificationofkukoamineaasanantiosteoporosisdrugtargetusingnetworkpharmacologyandexperimentverification
AT guanzhiyuan correctionidentificationofkukoamineaasanantiosteoporosisdrugtargetusingnetworkpharmacologyandexperimentverification
AT jinxiao correctionidentificationofkukoamineaasanantiosteoporosisdrugtargetusingnetworkpharmacologyandexperimentverification
AT guanzhiqiang correctionidentificationofkukoamineaasanantiosteoporosisdrugtargetusingnetworkpharmacologyandexperimentverification
AT jiangyanyun correctionidentificationofkukoamineaasanantiosteoporosisdrugtargetusingnetworkpharmacologyandexperimentverification